Evidence Hub

Coinfection With Nocardia exalbida and Mycobacterium tuberculosis Following Steroid Pulse Therapy: A Case Report and Literature Review

Inatomi S, Sakai Y, Yamaguchi N, Suzuki Y, Kasahara K

Cureus, 2026

Abstract

We report a case of pulmonary nocardiosis and pulmonary tuberculosis following steroid pulse therapy for presumed myelitis. A 74-year-old man with transthyretin amyloid cardiomyopathy, chronic heart failure, and type 2 diabetes mellitus received two courses of steroid pulse therapy for suspected inflammatory myelitis. One month later, he developed progressive dyspnea and was admitted to our hospital. Chest computed tomography revealed multifocal right-sided infiltrates and pleural effusion. Although empirical piperacillin/tazobactam was initiated for presumed bacterial pneumonia, sputum Gram and Kinyoun stains revealed thin, branching, partially acid-fast bacilli, and sequencing of the secA1 gene identified Nocardia exalbida. Polymerase chain reaction (PCR) analysis was positive for Mycobacterium tuberculosis. Pleural fluid culture yielded Nocardia species. The patient's condition improved following combined antituberculous and anti-nocardial therapy, along with optimized heart failure management. Coinfection with nocardiosis and tuberculosis should be considered in immunosuppressed patients following corticosteroid therapy.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free